Piśmiennictwo

1. Hyman PE, Milla PJ, Benninga MA, et al. Childhood functional gastrointestinal disorders: neonate/toddler. Gastroenterology. 2006;130:1519-1526.

2. Rasquin A, Lorenzo C, Forbes D, et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology. 2006;130:1527-1537.

3. Koletzko S, Jones NL, Goodman KJ, et al.; on behalf of the H. pylori working groups of ESPGHAN, NASPGHAN. Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr. 2011;53(2):230-243.

4. Graham DY, et al. A report card to grade Helicobacter pylori therapy. Helicobacter. 2007;12:275-278.

5. Francavilla R, Lionetti E, Castellaneta SP, et al. Improved efficacy of 10-day sequential treatment for Helicobacter pylori eradication in children: a randomized trial. Gastroenterology. 2005;129:1414-1419.

6. Francavilla R, Lionetti E, Castellaneta SP, et al. Improved efficacy of 10-day sequential treatment for Helicobacter pylori eradication in children: a randomized trial. Gastroenterology. 2005;129:1414-1419.

7. Albrecht P, Kotowska M, Szajewska H. Sequential Therapy Compared with Standard Triple Therapy for Helicobacter Pylori Eradication in Children: A Double-Blind, Randomized, Controlled Trial. J Pediatr. 2011;159(1):45-49.

8. Usta Y, Saltik-Temizel IN, Demir H, et al. Comparison of short- and longterm treatment protocols and the results of second-line quadruple therapy in children with Helicobacter pylori infection. J Gastroenterol. 2008;43(6):429-433.

9. Bahremand S, Nematollahi LR, Fourutan H, et al. Evaluation of triple and quadruple Helicobacter pylori eradication therapies in Iranian children: a randomized clinical trial. Eur J Gastroenterol Hepatol. 2006;18(5):511-514.

10. Gisbert JP, Calvet X. Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori. Clinical Experimental Gastroenterology. 2012;5:23-34.

11. Federico A, Nardone G, Gravina AG, et al. Efficacy of 5-Day Levofloxacin-Containing Concomitant Therapy in Eradication of Helicobacter pylori Infection. Gastroenterology. 2012;143(1):55-61.

12. Di Caro S, Franceschi F, Mariani A, et al. Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication. Dig Liver Dis. 2009;41(7):480-485.

13. Gisbert JP, Bermejo F, Castro-Fernández M, et al. H. pylori Study Group of the Asociación Española de Gastroenterología. Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients. Am J Gastroenterol. 2008;103(1):71-76.

14. Jodlowski TZ, Lam S, Ashby CR. Emerging therapies for the treatment of Helicobacter pylori infections. Ann Pharmacother. 2008;42:1621-1639.

15. Husby S, Koletzko S, Korponay-Szabó IR, et al. The ESPGHAN Working Group on Coeliac Disease Diagnosis. ESPGHAN guidelines for the diagnosis of coeliac disease in children and adolescents. An evidence-based approach. J Pediatr Gastroenterol Nutr J Pediatr Gastroenterol Nutr. 2012;54(1):136-160.

16. Giersiepen K, Lelgemann M, Stuhldreher N, et al. ESPGHAN Working Group on Coeliac Disease Diagnosis. Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report. J Pediatr Gastroenterol Nutr. 2012;54(2):229-241.

17. Karolewska-Bochenek K, Lazowska-Przeorek I, Albrecht P, et al. Epidemiology of Inflammatory Bowel Disease among Children in Poland. A Prospective, Population-Based, 2-Year Study, 2002-2004. Digestion. 2009;79(2):121-129.

18. Dignass A, Van Assche G, Lindsay JO, et al. for the European Crohn’s and Colitis Organisation (ECCO). The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: Current management. JCC. 2010;4:28-62.

19. Travis SPL, Stange EF, Lémann M, et al. for the European Crohn’s and Colitis Organisation (ECCO). European evidence-based Consensus on the management of ulcerative colitis: Current management. J Crohn’s Colitis. 2008;2:24-62.

20. Prince JS, Senac MO, Jr. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis in a child. Pediatr Radiol. 2003;33(9): 648-651.

21. Bonnard A, Seguier-Lipszyc E, Liguory C, et al. Laparoscopic approach as primary treatment of common bile duct stones in children. J Pediatr Surg. 2005;40(9):1459-1463.

22. Górczewska M, Jankowska I, Pawłowska J i wsp. Proponowany standard postępowania w kamicy pęcherzyka żółciowego u dzieci. Standardy Medyczne – Pediatria. 2011;8:3-9.